Skip to search formSkip to main contentSkip to account menu

Cefotetan

Known as: Cefotetanum, (6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid, Cefotetan [Chemical/Ingredient] 
A semi-synthetic, broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin antibiotic derived from cephalosporium. The bactericidal… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND:  Cefotetan can cause severe immune hemolytic anemia that may persist long after the drug is discontinued. To study… 
2000
2000
Numerous cases of drug‐induced hemolytic anemia have been described in patients treated with penicillin or cephalosporin. Second… 
1992
1992
Severe acute hemolytic anemia developed in a woman following treatment with multiple antibiotics for possible postpartum uterine… 
Review
1990
Review
1990
A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active beta… 
1988
1988
Excerpt To the editor: Antibiotics containing the methyl-tetrazolethiol-leaving group have been associated with reductions in the… 
1983
1983
Cefotetan, a novel 7 alpha-methoxy cephalosporin, was shown to be comparable to other third-generation cephalosporins when tested… 
1983
1983
Cefotetan, a third-generation cephalosporin, is extremely well tolerated by healthy Caucasian volunteers when given by…